At the invitation of the Co-Chair , representatives of the proponents of the two draft decisions , the European Community and the United States of America , briefly introduced them . Introducing his country 's proposed decision , the representative of the United States of America noted that , in accordance with decision XV/5 , in which Parties seeking essential-use exemptions for metered-dose inhalers were asked to elaborate plans of action including deadlines beyond which they would no longer seek essential-use exemptions for inhalers whose sole ingredient was salbutamol , his country had completed the regulatory process necessary to phase out such chlorofluorocarbon ( CFC ) based metered-dose inhalers by 31 December 2008 .